Story
AMD, Arm, and Tesla Lead Broad Rally in Technology Stocks
Summary
Mega-cap technology stocks, including Advanced Micro Devices (AMD), Arm Holdings (ARM), and Tesla (TSLA), posted significant gains on Monday, signaling strong investor sentiment in the semiconductor and electric vehicle sectors.
Several major technology companies saw their stock prices surge in Monday's trading session, with chip designers Arm and AMD leading the gains among mega-cap stocks. The rally points to renewed investor confidence in high-growth tech sectors.
According to market data from the session, shares of Arm (ARM) jumped 12.49%, while Advanced Micro Devices (AMD) climbed 8.95%. Electric vehicle manufacturer Tesla (TSLA) also participated in the rally, with its stock rising 3.69%.
Semiconductor Sector Shines
The positive momentum was particularly evident across the semiconductor industry. Beyond the notable increases for Arm and AMD, other key players in the chip ecosystem also ended the day higher.
- Applied Materials (AMAT): +3.07%
- KLA Corp (KLAC): +2.5%
- Micron Technology (MU): +2.18%
AdThe coordinated advance among these companies, which span chip design, manufacturing equipment, and memory, suggests a broad-based optimism for the sector's outlook.
Gains Extend Across Market Caps
The rally was not confined to the largest companies, as significant upward moves were seen in various other segments. In the large-cap space, biotechnology firm Moderna (MRNA) and media conglomerate Warner Bros. Discovery (WBD) both rose nearly 10%, with reported gains of 9.94% and 9.93%, respectively.
Mid-cap and small-cap stocks also saw standout performers. Cancer-screening company Grail (GRAL) recorded a substantial gain of 35.06%, while other smaller firms also experienced double-digit percentage increases, indicating a widespread risk-on appetite among investors during the trading day.
Read next
More on Stocks
Laekna's Cancer Drug Opatisumimab Earns Late-Breaking Abstract Status at ESMO Congress
Laekna announced its pivotal Phase IIb study for the bispecific antibody opatisumimab in late-stage neuroendocrine carcinoma has been selected for a Late-Breaking Abstract oral presentation at the European Society for Medical Oncology Congress. The company will also present findings from two other studies in proffered oral sessions.
Huatai Securities Raises RMB 1.9 Billion in Oversubscribed Perpetual Bond Sale
The Chinese brokerage secured a 1.85% coupon rate on the perpetual subordinated bonds, which saw strong demand with a subscription ratio of 4.77 times from professional investors.
Crypto-Linked Stocks Rally as Bitcoin Surges Past $85,000
Shares of companies with exposure to the cryptocurrency market, including MicroStrategy and Coinbase, gained on Monday after Bitcoin's price climbed more than 5% to break the $85,000 threshold.
Optical Communication Stocks Rise as AI-Focused ECOC Conference Begins
Shares of companies like Astera Labs and Corning rallied Monday, driven by investor optimism around new technologies for AI data centers being presented at the ECOC 2026 conference in Spain.